The Peptide Encyclopedia
Independent, sourced profiles of 30+ peptides. Each entry flags regulatory status honestly β approved medicine, research chemical, or somewhere in between β and links to primary research.
309 peptides
A small-molecule NNMT inhibitor (not a peptide) studied in preclinical metabolic research; included for completeness as it is commonly grouped with research peptides.
Abaloparatide (also known as Tymlos) is a peptide catalogued under Hormones & Metabolic (PTHrP analog). It is described as: PTH1R (RG-selective). Documented context: Osteoporosis. Neutral reference entry; EU status: EU-approved prescription medicine.
Acetyl decapeptide-3 (also known as Rejuline) is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Acetyl tetrapeptide-11 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Acetyl tetrapeptide-15 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Acetyl tetrapeptide-2 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Acetyl tetrapeptide-22 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Acetyl tetrapeptide-3 is a peptide catalogued under Skin (Hair growth). Neutral reference entry; EU status: EU cosmetic ingredient.
Acetyl tetrapeptide-5 (also known as Eyeseryl) is a peptide catalogued under Skin (Under-eye bags). Neutral reference entry; EU status: EU cosmetic ingredient.
Acetyl tetrapeptide-9 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Adipotide (also known as Prohibitin-TP01) is a peptide catalogued under Weight Loss & Metabolic (Pro-apoptotic peptide). It is described as: Prohibitin (adipose vasculature). Documented context: Obesity (preclinical). Neutral reference entry; EU status: not approved for human use (research use only).
Adrenocorticotropic hormone (also known as ACTH) is a peptide catalogued under Hormones & Metabolic (Pituitary hormone). It is described as: MC2 receptor. Documented context: Multiple sclerose; nefrotisch syndroom; infantiele spasmen. Neutral reference entry; EU status: EU-approved prescription medicine.
Afamelanotide (also known as Scenesse) is a peptide catalogued under Cognitive & Nootropic (MC1R agonist). It is described as: MC1R agonist. Documented context: Erythropoietic protoporphyria. Neutral reference entry; EU status: EU-approved prescription medicine.
Agalsidase alfa (also known as Replagal) is a peptide catalogued under Enzymes (Fabry). Neutral reference entry; EU status: EU-approved prescription medicine.
Agalsidase beta (also known as Fabrazyme) is a peptide catalogued under Enzymes (Fabry). Neutral reference entry; EU status: EU-approved prescription medicine.
AHK-Cu (also known as Ala-His-Lys copper) is a peptide catalogued under Skin (Copper peptide). It is described as: Hair follicle growth. Neutral reference entry; EU status: EU cosmetic ingredient.
Aldesleukin is a peptide catalogued under Immune. Neutral reference entry; EU status: EU-approved prescription medicine.
Alexamorelin is a peptide catalogued under Growth Hormone (GHRP). It is described as: Ghrelin receptor. Neutral reference entry; EU status: not approved for human use (research use only).
Alglucosidase alfa (also known as Myozyme) is a peptide catalogued under Enzymes (Pompe disease enzyme replacement). Neutral reference entry; EU status: EU-approved prescription medicine.
Alteplase (also known as Activase) is a peptide catalogued under Enzymes (Recombinant tPA). Documented context: Ischemic stroke; MI; PE. Neutral reference entry; EU status: EU-approved prescription medicine.
Anakinra (also known as Kineret) is a peptide catalogued under Immune (Recombinant IL-1RA). It is described as: IL-1 receptor. Documented context: RA; CAPS; STILL. Neutral reference entry; EU status: EU-approved prescription medicine.
Anidulafungin (also known as Eraxis) is a peptide catalogued under Cyclic & Antimicrobial (Echinocandin). It is described as: Ξ²-1,3-glucan synthase. Documented context: Invasive candidiasis. Neutral reference entry; EU status: EU-approved prescription medicine.
A modified fragment of human growth hormone (176-191) investigated for fat-metabolism effects; failed to show significant weight-loss efficacy in trials.
Argireline (also known as Acetyl hexapeptide-3) is a peptide catalogued under Skin (Neurotransmitter-inhibiting peptide). It is described as: SNAP-25/SNARE complex inhibitor. Documented context: Anti-wrinkle (topical). Neutral reference entry; EU status: EU cosmetic ingredient.
Asparaginase is a peptide catalogued under Enzymes. Neutral reference entry; EU status: EU-approved prescription medicine.
Atosiban (also known as Tractocile) is a peptide catalogued under Sexual Health (Oxytocin/vasopressin V1a antagonist). It is described as: Oxytocin receptor antagonist. Documented context: Preterm labor. Neutral reference entry; EU status: EU-approved prescription medicine.
Avalglucosidase alfa (also known as Nexviazyme) is a peptide catalogued under Enzymes (Pompe (2nd gen)). Neutral reference entry; EU status: EU-approved prescription medicine.
Bacitracin is a peptide catalogued under Cyclic & Antimicrobial (Cyclic peptide antibiotic). It is described as: Cell wall synthesis (undecaprenyl-PP). Documented context: Topical antibiotic. Neutral reference entry; EU status: EU-approved prescription medicine.
Biopeptide CL (also known as Palmitoyl tripeptide-28) is a peptide catalogued under Skin (Signal peptide). Neutral reference entry; EU status: EU cosmetic ingredient.
Biopeptide EL (also known as Palmitoyl oligopeptide) is a peptide catalogued under Skin (Signal peptide). Neutral reference entry; EU status: EU cosmetic ingredient.
A synthetic 20-amino-acid direct thrombin inhibitor (hirudin analog), FDA-approved as an anticoagulant during percutaneous coronary intervention.
A synthetic pentadecapeptide derived from a protein found in gastric juice. Studied extensively in animal models for tissue-healing effects; no completed human efficacy trials exist.
A melanocortin-receptor agonist peptide, FDA-approved (2019, Vyleesi) for acquired hypoactive sexual desire disorder in premenopausal women.
Bronchogen is a peptide catalogued under Bioregulators (Khavinson (bronchial)). Neutral reference entry; EU status: not approved for human use (research use only).
Buserelin (also known as Suprefact) is a peptide catalogued under Sexual Health (GnRH agonist). It is described as: GnRH receptor agonist. Documented context: Prostate cancer; endometriosis. Neutral reference entry; EU status: EU-approved prescription medicine.
Calaspargase pegol is a peptide catalogued under Enzymes. Neutral reference entry; EU status: EU-approved prescription medicine.
A 32-amino-acid peptide hormone, FDA-approved for postmenopausal osteoporosis, Paget disease and hypercalcemia; now a later-line option.
Carbetocin (also known as Duratocin) is a peptide catalogued under Sexual Health (Oxytocin analog). It is described as: Oxytocin receptor. Documented context: Postpartum hemorrhage prevention. Neutral reference entry; EU status: EU-approved prescription medicine.
Cardiogen is a peptide catalogued under Bioregulators (Khavinson (cardiac)). Neutral reference entry; EU status: not approved for human use (research use only).
Carfilzomib (also known as Kyprolis) is a peptide catalogued under Therapeutic Peptides (Proteasome inhibitor (tetrapeptide)). It is described as: 20S proteasome. Documented context: Multiple myeloma. Neutral reference entry; EU status: EU-approved prescription medicine.
Caspofungin (also known as Cancidas) is a peptide catalogued under Cyclic & Antimicrobial (Echinocandin). It is described as: Ξ²-1,3-glucan synthase. Documented context: Invasive candidiasis/aspergillose. Neutral reference entry; EU status: EU-approved prescription medicine.
A porcine-brain-derived peptide preparation marketed in some countries and studied in stroke and dementia trials; not FDA-approved.
Cerebrolysin components is a peptide catalogued under Cognitive & Nootropic. Neutral reference entry; EU status: EU-approved prescription medicine.
Cerliponase alfa (also known as Brineura) is a peptide catalogued under Enzymes (CLN2 disease). Neutral reference entry; EU status: EU-approved prescription medicine.
Ceruletide is a peptide catalogued under Gastrointestinal. Neutral reference entry; EU status: EU-approved prescription medicine.
Cetrorelix (also known as Cetrotide) is a peptide catalogued under Sexual Health (GnRH antagonist). It is described as: GnRH receptor antagonist. Documented context: Assisted reproduction. Neutral reference entry; EU status: EU-approved prescription medicine.
Cholecystokinin (also known as CCK) is a peptide catalogued under Gastrointestinal (Gut hormone). Neutral reference entry; EU status: EU-approved prescription medicine.
Chonluten is a peptide catalogued under Bioregulators (Khavinson tripeptide (lung)). Neutral reference entry; EU status: not approved for human use (research use only).
Choriogonadotropin alfa (also known as Ovidrel) is a peptide catalogued under Sexual Health (Recombinant hCG). Neutral reference entry; EU status: EU-approved prescription medicine.
Ciclosporin (also known as Cyclosporine A) is a peptide catalogued under Cyclic & Antimicrobial (Immunosuppressant). It is described as: Cyclophilin/calcineurin. Documented context: Transplant rejection; autoimmune. Neutral reference entry; EU status: EU-approved prescription medicine.
A long-acting growth-hormone-releasing hormone analog. The DAC variant was studied in early human pharmacokinetic trials.
Colistin (also known as Polymyxin E) is a peptide catalogued under Cyclic & Antimicrobial (Polymyxin). It is described as: LPS/outer membrane disruption. Documented context: MDR Gram-negative infections. Neutral reference entry; EU status: EU-approved prescription medicine.
Copper heptapeptide-14 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Copper palmitoyl heptapeptide-14 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Copper tripeptide-1 (also known as GHK-Cu) is a peptide catalogued under Skin (Copper peptide). It is described as: Wound healing; collagen stimulation. Documented context: Wound healing; anti-aging. Neutral reference entry; EU status: EU cosmetic ingredient.
Corifollitropin alfa (also known as Elonva) is a peptide catalogued under Sexual Health (Long-acting FSH-hCG hybrid). Neutral reference entry; EU status: EU-approved prescription medicine.
Cortagen (also known as Ala-Glu-Asp-Pro) is a peptide catalogued under Bioregulators (Khavinson tetrapeptide (brain)). Neutral reference entry; EU status: not approved for human use (research use only).
Cosyntropin (also known as Tetracosactide) is a peptide catalogued under Hormones & Metabolic (ACTH analog (1-24)). It is described as: MC2 receptor. Documented context: Diagnostic (adrenal function). Neutral reference entry; EU status: EU-approved prescription medicine.
Dalbavancin (also known as Dalvance) is a peptide catalogued under Cyclic & Antimicrobial (Lipoglycopeptide). It is described as: Cell wall synthesis. Documented context: Acute bacterial skin infections. Neutral reference entry; EU status: EU-approved prescription medicine.
Daptomycin (also known as Cubicin) is a peptide catalogued under Cyclic & Antimicrobial (Cyclic lipopeptide). It is described as: Membrane depolarization. Documented context: MRSA; complicated skin infections; bacteremia. Neutral reference entry; EU status: EU-approved prescription medicine.
Darbepoetin alfa (also known as Aranesp) is a peptide catalogued under Immune (Hyperglycosylated EPO). Neutral reference entry; EU status: EU-approved prescription medicine.
Dasiglucagon (also known as Zegalogue) is a peptide catalogued under Hormones & Metabolic (Glucagon analog). It is described as: Glucagon receptor agonist. Documented context: Severe hypoglycemia. Neutral reference entry; EU status: EU-approved prescription medicine.
Decapeptide-10 is a peptide catalogued under Skin (Hair growth (bioengineered)). Neutral reference entry; EU status: EU cosmetic ingredient.
Decapeptide-12 (also known as Lumixyl) is a peptide catalogued under Skin (Skin brightening (tyrosinase inhibitor)). Neutral reference entry; EU status: EU cosmetic ingredient.
Decapeptide-4 (also known as Follicusan) is a peptide catalogued under Skin (Hair loss). Neutral reference entry; EU status: EU cosmetic ingredient.
Degarelix (also known as Firmagon) is a peptide catalogued under Sexual Health (GnRH antagonist). It is described as: GnRH receptor antagonist. Documented context: Prostate cancer. Neutral reference entry; EU status: EU-approved prescription medicine.
Delta sleep-inducing peptide is a peptide catalogued under Cognitive & Nootropic. Neutral reference entry; EU status: not approved for human use (research use only).
Desmopressin (also known as DDAVP) is a peptide catalogued under Sexual Health (Vasopressin analog). It is described as: V2 receptor selective. Documented context: Diabetes insipidus; enuresis; von Willebrand. Neutral reference entry; EU status: EU-approved prescription medicine.
An angiotensin-IV-derived peptide studied in preclinical models for synaptogenesis and cognition; no human approval.
Ecallantide (also known as Kalbitor) is a peptide catalogued under Therapeutic Peptides (Plasma kallikrein inhibitor). It is described as: Plasma kallikrein. Documented context: Hereditary angioedema. Neutral reference entry; EU status: EU-approved prescription medicine.
Efbemalenograstim alfa is a peptide catalogued under Immune. Neutral reference entry; EU status: EU-approved prescription medicine.
Elosulfase alfa (also known as Vimizim) is a peptide catalogued under Enzymes (MPS IVA (Morquio)). Neutral reference entry; EU status: EU-approved prescription medicine.
Endoluten is a peptide catalogued under Bioregulators (Khavinson (pineal)). Neutral reference entry; EU status: not approved for human use (research use only).
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) studied in Russian research for effects on the pineal gland and telomerase; human evidence is limited.
A cyclic heptapeptide glycoprotein IIb/IIIa inhibitor (antiplatelet), FDA-approved for acute coronary syndrome and percutaneous coronary intervention.
Erythropoietin (epoetin alfa) is a peptide catalogued under Immune. Neutral reference entry; EU status: EU-approved prescription medicine.
Etelcalcetide (also known as Parsabiv) is a peptide catalogued under Therapeutic Peptides (Calcimimetic (D-amino acid heptapeptide)). It is described as: CaSR. Documented context: Secundaire hyperparathyroidism (CKD). Neutral reference entry; EU status: EU-approved prescription medicine.
Everolimus is a peptide catalogued under Cyclic & Antimicrobial. Neutral reference entry; EU status: EU-approved prescription medicine.
Examorelin (also known as Hexarelin) is a peptide catalogued under Growth Hormone (GHRP). Neutral reference entry; EU status: not approved for human use (research use only).
Eyeliss (also known as Palmitoyl tetrapeptide-7 + hesperidin methyl chalcone) is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Felypressin (also known as Octapressin) is a peptide catalogued under Sexual Health (Vasopressin analog). It is described as: V1 receptor agonist. Documented context: Local anesthesie adjuvans. Neutral reference entry; EU status: EU-approved prescription medicine.
Filgrastim is a peptide catalogued under Immune. Neutral reference entry; EU status: EU-approved prescription medicine.
Follicle-stimulating hormone (also known as FSH) is a peptide catalogued under Sexual Health (Pituitary hormone (dimer)). Documented context: Infertility. Neutral reference entry; EU status: EU-approved prescription medicine.
Follitropin alfa (also known as Gonal-F) is a peptide catalogued under Sexual Health (Recombinant FSH). Neutral reference entry; EU status: EU-approved prescription medicine.
Follitropin beta (also known as Puregon) is a peptide catalogued under Sexual Health (Recombinant FSH). Neutral reference entry; EU status: EU-approved prescription medicine.
Follitropin delta (also known as Rekovelle) is a peptide catalogued under Sexual Health (Recombinant FSH). Neutral reference entry; EU status: EU-approved prescription medicine.
FOXO4-DRI is a peptide catalogued under Longevity & Anti-Aging. Neutral reference entry; EU status: not approved for human use (research use only).
Galsulfase (also known as Naglazyme) is a peptide catalogued under Enzymes (MPS VI). Neutral reference entry; EU status: EU-approved prescription medicine.
Ganirelix (also known as Antagon) is a peptide catalogued under Sexual Health (GnRH antagonist). It is described as: GnRH receptor antagonist. Documented context: Assisted reproduction. Neutral reference entry; EU status: EU-approved prescription medicine.
A copper-binding tripeptide present naturally in human plasma. Widely used in topical cosmetic formulations; studied for skin and wound-related effects.
A growth-hormone-releasing peptide and ghrelin-receptor agonist used as a diagnostic agent for growth-hormone deficiency in some countries.
A first-generation growth-hormone-releasing hexapeptide and ghrelin-receptor agonist studied for GH stimulation and appetite effects.
Glucagon (also known as GlucaGen) is a peptide catalogued under Hormones & Metabolic (Pancreatic hormone). It is described as: Glucagon receptor. Documented context: Severe hypoglycemia. Neutral reference entry; EU status: EU-approved prescription medicine.
Gonadorelin (also known as GnRH) is a peptide catalogued under Sexual Health (GnRH). It is described as: GnRH receptor. Documented context: Hypothalamic amenorrhea; diagnostic. Neutral reference entry; EU status: EU-approved prescription medicine.
Goserelin (also known as Zoladex) is a peptide catalogued under Sexual Health (GnRH agonist). It is described as: GnRH receptor agonist. Documented context: Prostate/breast cancer; endometriosis. Neutral reference entry; EU status: EU-approved prescription medicine.
Gramicidin is a peptide catalogued under Cyclic & Antimicrobial. Neutral reference entry; EU status: EU-approved prescription medicine.
Growth hormone (also known as Somatropin) is a peptide catalogued under Growth Hormone (Pituitary hormone). It is described as: GH receptor. Documented context: GH deficiency; Turner syndrome; PWS; adult GHD. Neutral reference entry; EU status: EU-approved prescription medicine.
Haloxyl (also known as N-hydroxysuccinimide + palmitoyl peptides) is a peptide catalogued under Skin (Dark circles reduction). Neutral reference entry; EU status: EU cosmetic ingredient.
Hexapeptide-10 (also known as Serilesine) is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Hexapeptide-12 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Hexapeptide-14 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Hexapeptide-45 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Hexapeptide-9 (also known as Collaxyl) is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
A potent synthetic growth-hormone-releasing hexapeptide studied for GH release and cardiovascular effects in early research.
Histrelin (also known as Vantas) is a peptide catalogued under Sexual Health (GnRH agonist). It is described as: GnRH receptor agonist. Documented context: Prostate cancer; precocious puberty. Neutral reference entry; EU status: EU-approved prescription medicine.
Human chorionic gonadotropin (also known as hCG) is a peptide catalogued under Sexual Health (Placental). Documented context: Infertility; cryptorchidism. Neutral reference entry; EU status: EU-approved prescription medicine.
A mitochondrial-derived peptide studied for cytoprotective and metabolic signaling roles in aging research.
Ibrexafungerp (also known as Brexafemme) is a peptide catalogued under Cyclic & Antimicrobial (Triterpenoid (glucan synthase)). It is described as: Ξ²-1,3-glucan synthase. Documented context: VVC. Neutral reference entry; EU status: EU-approved prescription medicine.
Icatibant (also known as Firazyr) is a peptide catalogued under Therapeutic Peptides (Bradykinin B2 antagonist). It is described as: B2R antagonist. Documented context: Hereditary angioedema. Neutral reference entry; EU status: EU-approved prescription medicine.
Idursulfase (also known as Elaprase) is a peptide catalogued under Enzymes (MPS II (Hunter)). Neutral reference entry; EU status: EU-approved prescription medicine.
IGF-1 DES is a peptide catalogued under Growth Hormone. Neutral reference entry; EU status: not approved for human use (research use only).
IGF-1 LR3 is a peptide catalogued under Growth Hormone. Neutral reference entry; EU status: not approved for human use (research use only).
Imiglucerase (also known as Cerezyme) is a peptide catalogued under Enzymes (Gaucher enzyme replacement). Neutral reference entry; EU status: EU-approved prescription medicine.
Insulin aspart (also known as NovoLog) is a peptide catalogued under Hormones & Metabolic (Rapid-acting insulin analogue). It is described as: Insulin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.
Insulin degludec (also known as Tresiba) is a peptide catalogued under Hormones & Metabolic (Ultra-long-acting insulin). It is described as: Insulin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.
Insulin degludec/aspart (also known as Ryzodeg) is a peptide catalogued under Hormones & Metabolic (Insulin combination). It is described as: Insulin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.
Insulin detemir (also known as Levemir) is a peptide catalogued under Hormones & Metabolic (Long-acting insulin analogue). It is described as: Insulin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.
Insulin glargine (also known as Lantus) is a peptide catalogued under Hormones & Metabolic (Long-acting insulin analogue). It is described as: Insulin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.
Insulin glulisine (also known as Apidra) is a peptide catalogued under Hormones & Metabolic (Rapid-acting insulin analogue). It is described as: Insulin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.
Insulin human (also known as Regular insulin) is a peptide catalogued under Hormones & Metabolic (Insulin). It is described as: Insulin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.
Insulin icodec (also known as Awiqli) is a peptide catalogued under Hormones & Metabolic (Once-weekly basal insulin). It is described as: Insulin receptor agonist. Documented context: Type 2 diabetes. Neutral reference entry; EU status: EU-approved prescription medicine.
Insulin lispro (also known as Humalog) is a peptide catalogued under Hormones & Metabolic (Rapid-acting insulin analogue). It is described as: Insulin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.
Insulin-like growth factor 1 (also known as IGF-1) is a peptide catalogued under Growth Hormone. Neutral reference entry; EU status: EU-approved prescription medicine.
Interferon alfa-2a (also known as Roferon-A) is a peptide catalogued under Immune (IFN-Ξ±). Neutral reference entry; EU status: EU-approved prescription medicine.
Interferon alfa-2b (also known as Intron A) is a peptide catalogued under Immune (IFN-Ξ±). Neutral reference entry; EU status: EU-approved prescription medicine.
Interferon beta-1a (also known as Avonex) is a peptide catalogued under Immune (IFN-Ξ²). Documented context: MS. Neutral reference entry; EU status: EU-approved prescription medicine.
Interferon beta-1b (also known as Betaseron) is a peptide catalogued under Immune (IFN-Ξ²). Neutral reference entry; EU status: EU-approved prescription medicine.
Interferon gamma-1b (also known as Actimmune) is a peptide catalogued under Immune (IFN-Ξ³). Neutral reference entry; EU status: EU-approved prescription medicine.
A selective growth-hormone secretagogue (ghrelin-receptor agonist) studied for its ability to stimulate growth-hormone release with minimal effect on cortisol or prolactin.
A fragment of the kisspeptin neuropeptide studied in human reproductive-endocrinology research for its role in gonadotropin release.
A tripeptide fragment of alpha-melanocyte-stimulating hormone studied for anti-inflammatory activity in preclinical models.
Lanreotide (also known as Somatuline) is a peptide catalogued under Hormones & Metabolic (Somatostatin analog). It is described as: SSTR2/5. Documented context: Acromegaly; neuroendocrine tumors. Neutral reference entry; EU status: EU-approved prescription medicine.
An investigational peptide studied as a tight-junction regulator for celiac disease in human clinical trials; not approved.
Laronidase (also known as Aldurazyme) is a peptide catalogued under Enzymes (MPS I). Neutral reference entry; EU status: EU-approved prescription medicine.
Lenograstim is a peptide catalogued under Immune. Neutral reference entry; EU status: EU-approved prescription medicine.
Leuphasyl (also known as Pentapeptide-18) is a peptide catalogued under Skin (Enkephalin-like). It is described as: Enkephalin receptor. Neutral reference entry; EU status: EU cosmetic ingredient.
Leuprolide (also known as Leuprorelin) is a peptide catalogued under Sexual Health (GnRH agonist). It is described as: GnRH receptor agonist. Documented context: Prostate cancer; endometriosis; precocious puberty. Neutral reference entry; EU status: EU-approved prescription medicine.
Linaclotide (also known as Linzess) is a peptide catalogued under Gastrointestinal (Guanylate cyclase-C agonist). It is described as: GC-C receptor. Documented context: IBS-C; chronic idiopathic constipation. Neutral reference entry; EU status: EU-approved prescription medicine.
Livagen (also known as Lys-Glu-Asp-Ala) is a peptide catalogued under Bioregulators (Khavinson tetrapeptide (liver)). Neutral reference entry; EU status: not approved for human use (research use only).
Lonapegsomatropin (also known as Skytrofa) is a peptide catalogued under Growth Hormone (Long-acting PEGylated GH). It is described as: GH receptor. Documented context: Pediatric GHD. Neutral reference entry; EU status: EU-approved prescription medicine.
Luteinizing hormone (also known as LH) is a peptide catalogued under Sexual Health (Pituitary hormone). Documented context: Infertility. Neutral reference entry; EU status: EU-approved prescription medicine.
Matrixyl 3000 (also known as Pal-GHK + Pal-GQPR combination) is a peptide catalogued under Skin (Peptide combination). Neutral reference entry; EU status: EU cosmetic ingredient.
Matrixyl synthe'6 (also known as Palmitoyl tripeptide-38) is a peptide catalogued under Skin (Signal peptide). It is described as: 6 skin proteins stimulation. Neutral reference entry; EU status: EU cosmetic ingredient.
Mecasermin (also known as Increlex) is a peptide catalogued under Growth Hormone (Recombinant IGF-1). It is described as: IGF-1 receptor. Documented context: Severe primary IGF-1 deficiency. Neutral reference entry; EU status: EU-approved prescription medicine.
Melanotan I is a peptide catalogued under Sexual Health. Neutral reference entry; EU status: not approved for human use (research use only).
A synthetic melanocortin agonist studied for skin pigmentation and sexual function. Sold illegally in many regions; associated with notable safety concerns including melanoma risk discussion.
Menotropin (also known as hMG) is a peptide catalogued under Sexual Health (Human menopausal gonadotropin). Documented context: Infertility. Neutral reference entry; EU status: EU-approved prescription medicine.
Methoxy polyethylene glycol-epoetin beta (also known as Mircera) is a peptide catalogued under Immune (PEG-EPO). Neutral reference entry; EU status: EU-approved prescription medicine.
MGF (IGF-1 Ec) is a peptide catalogued under Growth Hormone. Neutral reference entry; EU status: not approved for human use (research use only).
Micafungin (also known as Mycamine) is a peptide catalogued under Cyclic & Antimicrobial (Echinocandin). It is described as: Ξ²-1,3-glucan synthase. Documented context: Candidemia; candidose. Neutral reference entry; EU status: EU-approved prescription medicine.
A modified, stabilized fragment of growth-hormone-releasing hormone (1-29) studied alongside ghrelin-receptor agonists in research settings.
Molgramostim (also known as rhGM-CSF) is a peptide catalogued under Immune (GM-CSF). Neutral reference entry; EU status: EU-approved prescription medicine.
Motixafortide (also known as Aphexda) is a peptide catalogued under Therapeutic Peptides (CXCR4 antagonist). It is described as: CXCR4. Documented context: Stem cell mobilization multiple myeloma. Neutral reference entry; EU status: EU-approved prescription medicine.
A mitochondrial-derived peptide studied for roles in metabolic regulation, insulin sensitivity, and exercise physiology.
Myristoyl pentapeptide-17 is a peptide catalogued under Skin (Eyelash-lengthening peptide). Neutral reference entry; EU status: EU cosmetic ingredient.
Myristoyl tetrapeptide-12 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
N-Acetyl Semax is a peptide catalogued under Cognitive & Nootropic. Neutral reference entry; EU status: not approved for human use (research use only).
N-Acetyl Semax Amidate (also known as NA-Semax-amidate) is a peptide catalogued under Cognitive & Nootropic (Semax derivative). Neutral reference entry; EU status: not approved for human use (research use only).
Nafarelin (also known as Synarel) is a peptide catalogued under Sexual Health (GnRH agonist). It is described as: GnRH receptor agonist. Documented context: Endometriosis; precocious puberty. Neutral reference entry; EU status: EU-approved prescription medicine.
Recombinant human B-type natriuretic peptide, FDA-approved (2001) for acute decompensated heart failure but largely abandoned after neutral outcome trials.
Neurotensin (also known as NT) is a peptide catalogued under Cognitive & Nootropic (Endogeen). Neutral reference entry; EU status: not approved for human use (research use only).
Nonapeptide-1 (also known as Melanostatin) is a peptide catalogued under Skin (Skin whitening). It is described as: MSH antagonist. Neutral reference entry; EU status: EU cosmetic ingredient.
Nonapeptide-3 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Nonapeptide-7 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Noopept is a peptide catalogued under Cognitive & Nootropic. Neutral reference entry; EU status: available as an EU supplement.
NPH insulin (also known as Isophane insulin) is a peptide catalogued under Hormones & Metabolic (Intermediate-acting insulin). It is described as: Insulin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.
Octapeptide-2 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Octapeptide-3 (also known as SNAP-8) is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Octreotide (also known as Sandostatin) is a peptide catalogued under Hormones & Metabolic (Somatostatin analog). It is described as: SSTR2/5. Documented context: Acromegaly; carcinoid tumor; VIPoma. Neutral reference entry; EU status: EU-approved prescription medicine.
Oligopeptide-1 (also known as EGF (rh-Oligopeptide-1)) is a peptide catalogued under Skin (EGF derivative). Neutral reference entry; EU status: EU cosmetic ingredient.
Oligopeptide-2 (also known as rh-IGF) is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Oligopeptide-20 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Oligopeptide-24 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Oritavancin (also known as Orbactiv) is a peptide catalogued under Cyclic & Antimicrobial (Lipoglycopeptide). It is described as: Cell wall + membrane. Documented context: ABSSSI. Neutral reference entry; EU status: EU-approved prescription medicine.
Ovagen is a peptide catalogued under Bioregulators (Khavinson (liver)). Neutral reference entry; EU status: not approved for human use (research use only).
Oxytocin (also known as Pitocin) is a peptide catalogued under Sexual Health (Neurohypophyseal hormone). It is described as: Oxytocin receptor. Documented context: Labor induction; postpartum hemorrhage. Neutral reference entry; EU status: EU-approved prescription medicine.
A ciliary-neurotrophic-factor-derived peptidomimetic studied in preclinical neurodegeneration models; not approved for human use.
Recombinant human keratinocyte growth factor, FDA-approved to reduce severe oral mucositis in blood-cancer patients undergoing stem-cell transplant.
Palmitoyl dipeptide-52 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl heptapeptide is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl hexapeptide-12 (also known as Biopeptide EL) is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl hexapeptide-14 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl oligopeptide (also known as Pal-GHK) is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl pentapeptide-3 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl pentapeptide-4 (also known as Matrixyl) is a peptide catalogued under Skin (Signal peptide (collagen synthesis)). It is described as: Collagen I/III/IV stimulation. Documented context: Anti-aging skincare. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl pentapeptide-5 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl tetrapeptide-10 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl tetrapeptide-20 (also known as Cynatine) is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl tetrapeptide-5 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl tetrapeptide-7 (also known as Rigin) is a peptide catalogued under Skin (Signal peptide). It is described as: Anti-inflammatory (IL-6 reduction). Documented context: Anti-aging skincare. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl tripeptide-1 (also known as Pal-GHK) is a peptide catalogued under Skin (Signal peptide). It is described as: Collagen stimulation. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl tripeptide-11 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl tripeptide-20 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl tripeptide-29 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl tripeptide-3 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl tripeptide-30 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl tripeptide-37 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl tripeptide-38 (also known as Matrixyl synthe'6) is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Palmitoyl tripeptide-8 is a peptide catalogued under Skin (Rosacea). Neutral reference entry; EU status: EU cosmetic ingredient.
Palopegteriparatide (also known as TransCon PTH) is a peptide catalogued under Hormones & Metabolic (Long-acting PTH prodrug). It is described as: PTH1R. Documented context: Hypoparathyroidism. Neutral reference entry; EU status: EU-approved prescription medicine.
Parathyroid hormone (also known as PTH) is a peptide catalogued under Hormones & Metabolic (Full-length rhPTH (1-84)). It is described as: PTH1R. Documented context: Hypoparathyroidism. Neutral reference entry; EU status: EU-approved prescription medicine.
Pasireotide (also known as Signifor) is a peptide catalogued under Hormones & Metabolic (Multi-receptor somatostatin analog). It is described as: SSTR1/2/3/5. Documented context: Cushing disease; acromegaly. Neutral reference entry; EU status: EU-approved prescription medicine.
PEG-MGF is a peptide catalogued under Growth Hormone. Neutral reference entry; EU status: not approved for human use (research use only).
Pegaspargase is a peptide catalogued under Enzymes. Neutral reference entry; EU status: EU-approved prescription medicine.
Pegcetacoplan (also known as Empaveli) is a peptide catalogued under Therapeutic Peptides (Compstatin analog (PEGylated)). It is described as: C3 complement. Documented context: PNH; GA. Neutral reference entry; EU status: EU-approved prescription medicine.
Pegfilgrastim (also known as Neulasta) is a peptide catalogued under Immune (PEG-G-CSF). Neutral reference entry; EU status: EU-approved prescription medicine.
Peginterferon alfa-2a (also known as Pegasys) is a peptide catalogued under Immune (PEG-IFN-Ξ±). Neutral reference entry; EU status: EU-approved prescription medicine.
Peginterferon alfa-2b (also known as PegIntron) is a peptide catalogued under Immune (PEG-IFN-Ξ±). Neutral reference entry; EU status: EU-approved prescription medicine.
Peginterferon beta-1a (also known as Plegridy) is a peptide catalogued under Immune (PEG-IFN-Ξ²). Neutral reference entry; EU status: EU-approved prescription medicine.
Pegloticase (also known as Krystexxa) is a peptide catalogued under Enzymes (PEG-urate oxidase). Neutral reference entry; EU status: EU-approved prescription medicine.
Pegunigalsidase alfa (also known as Elfabrio) is a peptide catalogued under Enzymes (Fabry (PEG)). Neutral reference entry; EU status: EU-approved prescription medicine.
A PEGylated phenylalanine ammonia-lyase enzyme, FDA-approved (2018, Palynziq) to lower blood phenylalanine in adults with phenylketonuria; boxed warning for anaphylaxis.
Pegvisomant (also known as Somavert) is a peptide catalogued under Hormones & Metabolic (GH receptor antagonist (PEGylated)). It is described as: GH receptor antagonist. Documented context: Acromegaly. Neutral reference entry; EU status: EU-approved prescription medicine.
Pentagastrin (also known as Peptavlon) is a peptide catalogued under Gastrointestinal (Gastrin analog). It is described as: Gastrin receptor. Documented context: Diagnostic (gastric acid). Neutral reference entry; EU status: EU-approved prescription medicine.
Pentapeptide-17 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Pentapeptide-34 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Peptamide 6 (also known as Hexapeptide-11) is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Pinealon (also known as Glu-Asp-Arg) is a peptide catalogued under Bioregulators (Khavinson tripeptide (pineal)). Neutral reference entry; EU status: not approved for human use (research use only).
Plecanatide (also known as Trulance) is a peptide catalogued under Gastrointestinal (Guanylate cyclase-C agonist). It is described as: GC-C receptor. Documented context: Chronic idiopathic constipation; IBS-C. Neutral reference entry; EU status: EU-approved prescription medicine.
Plitidepsin (also known as Aplidin) is a peptide catalogued under Cyclic & Antimicrobial (Depsipeptide (anticancer/COVID)). It is described as: eEF1A2. Documented context: Multiple myeloma; COVID-19. Neutral reference entry; EU status: EU-approved prescription medicine.
Polymyxin B is a peptide catalogued under Cyclic & Antimicrobial (Polymyxin (cyclic lipopeptide)). It is described as: LPS/outer membrane. Documented context: Multi-resistant Gram-negative infections. Neutral reference entry; EU status: EU-approved prescription medicine.
Pramlintide (also known as Symlin) is a peptide catalogued under Weight Loss & Metabolic (Amylin analogue). It is described as: Amylin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.
Prostamax is a peptide catalogued under Bioregulators (Khavinson (prostate)). Neutral reference entry; EU status: not approved for human use (research use only).
A melanocortin receptor agonist approved (as Vyleesi) for hypoactive sexual desire disorder in premenopausal women.
Rasburicase (also known as Elitek) is a peptide catalogued under Enzymes (Recombinant urate oxidase). Neutral reference entry; EU status: EU-approved prescription medicine.
An investigational triple GIP/GLP-1/glucagon receptor agonist in late-stage clinical trials for obesity; not yet approved.
Reteplase (also known as Retavase) is a peptide catalogued under Enzymes (Modified tPA). Neutral reference entry; EU status: EU-approved prescription medicine.
Rezafungin (also known as Rezzayo) is a peptide catalogued under Cyclic & Antimicrobial (Long-acting echinocandin). It is described as: Ξ²-1,3-glucan synthase. Documented context: Candidemia. Neutral reference entry; EU status: EU-approved prescription medicine.
Rh-Polypeptide-1 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Rh-Polypeptide-11 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Rh-Polypeptide-3 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Romidepsin (also known as Istodax) is a peptide catalogued under Cyclic & Antimicrobial (Depsipeptide (HDAC inhibitor)). It is described as: HDAC. Documented context: CTCL; PTCL. Neutral reference entry; EU status: EU-approved prescription medicine.
Romiplostim (also known as Nplate) is a peptide catalogued under Immune (TPO receptor agonist peptibody). It is described as: TPO receptor. Documented context: ITP. Neutral reference entry; EU status: EU-approved prescription medicine.
Salmon calcitonin (also known as Miacalcin) is a peptide catalogued under Hormones & Metabolic (Calcitonin analog). It is described as: Calcitonin receptor agonist. Documented context: Osteoporosis; Paget disease; hypercalcemia. Neutral reference entry; EU status: EU-approved prescription medicine.
Sargramostim (also known as GM-CSF) is a peptide catalogued under Immune (GM-CSF). Documented context: Bone marrow recovery. Neutral reference entry; EU status: EU-approved prescription medicine.
Sebelipase alfa (also known as Kanuma) is a peptide catalogued under Enzymes (Lysosomal acid lipase deficiency). Neutral reference entry; EU status: EU-approved prescription medicine.
Secretin (also known as ChiRhoStim) is a peptide catalogued under Gastrointestinal (Secretin family). It is described as: Secretin receptor. Documented context: Diagnostic (pancreas). Neutral reference entry; EU status: EU-approved prescription medicine.
A synthetic analog of the endogenous peptide tuftsin, studied in Russia for anxiolytic and nootropic effects.
A GLP-1 receptor agonist approved for type 2 diabetes (Ozempic/Rybelsus) and chronic weight management (Wegovy). One of the most rigorously trialed metabolic drugs.
A synthetic peptide derived from adrenocorticotropic hormone fragment (4-10), studied in Russia for neuroprotective and cognitive effects.
A growth-hormone-releasing hormone analog historically used in diagnostic testing of pituitary function; once marketed as Geref.
Setmelanotide (also known as Imcivree) is a peptide catalogued under Cognitive & Nootropic (MC4R agonist). It is described as: MC4R agonist. Documented context: Genetic obesity (POMC/LEPR/PCSK1/BBS). Neutral reference entry; EU status: EU-approved prescription medicine.
Sh-Oligopeptide-1 (also known as Synthetic EGF) is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Sh-Oligopeptide-2 (also known as Synthetic IGF-1) is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Sh-Polypeptide-11 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Sh-Polypeptide-15 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Sh-Polypeptide-16 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Sh-Polypeptide-20 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Sh-Polypeptide-9 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Sincalide (also known as Kinevac) is a peptide catalogued under Gastrointestinal (CCK analog). It is described as: CCK-A receptor. Documented context: Diagnostic (gallbladder). Neutral reference entry; EU status: EU-approved prescription medicine.
Sirolimus is a peptide catalogued under Cyclic & Antimicrobial. Neutral reference entry; EU status: EU-approved prescription medicine.
SNAP-8 (also known as Acetyl octapeptide-3) is a peptide catalogued under Skin (Neurotransmitter-inhibiting). It is described as: SNARE complex. Neutral reference entry; EU status: EU cosmetic ingredient.
Somapacitan (also known as Sogroya) is a peptide catalogued under Hormones & Metabolic (Long-acting GH analog). It is described as: GH receptor. Documented context: GHD adults/children. Neutral reference entry; EU status: EU-approved prescription medicine.
Somatostatin (also known as SST) is a peptide catalogued under Hormones & Metabolic (Somatostatin). It is described as: Somatostatin receptors (SSTR1-5). Documented context: GI bleeding; endocrine tumors. Neutral reference entry; EU status: EU-approved prescription medicine.
Somatrogon (also known as Ngenla) is a peptide catalogued under Growth Hormone (Long-acting GH analog). It is described as: GH receptor. Documented context: Growth hormone deficiency. Neutral reference entry; EU status: EU-approved prescription medicine.
SS-31 (Elamipretide) is a peptide catalogued under Longevity & Anti-Aging. Neutral reference entry; EU status: EU-approved prescription medicine.
Streptokinase (also known as Streptase) is a peptide catalogued under Enzymes (Fibrinolytic). Neutral reference entry; EU status: EU-approved prescription medicine.
Substance P (also known as SP) is a peptide catalogued under Cognitive & Nootropic (Tachykinin). It is described as: NK1 receptor. Neutral reference entry; EU status: not approved for human use (research use only).
Syn-Ake (also known as Dipeptide diaminobutyroyl benzylamide diacetate) is a peptide catalogued under Skin (Waglerin-1 mimetic). It is described as: Muscle nAChR antagonist. Neutral reference entry; EU status: EU cosmetic ingredient.
Syn-Coll (also known as Palmitoyl tripeptide-5) is a peptide catalogued under Skin (TGF-Ξ² mimic). It is described as: TSP-1 stimulation. Neutral reference entry; EU status: EU cosmetic ingredient.
Syn-Tacks (also known as Palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine) is a peptide catalogued under Skin (Laminin-5 mimetic). Neutral reference entry; EU status: EU cosmetic ingredient.
Tacrolimus is a peptide catalogued under Cyclic & Antimicrobial. Neutral reference entry; EU status: EU-approved prescription medicine.
Taliglucerase alfa (also known as Elelyso) is a peptide catalogued under Enzymes (Gaucher (plant cell)). Neutral reference entry; EU status: EU-approved prescription medicine.
A synthetic peptide related to thymosin beta-4, a naturally occurring actin-regulating protein. Studied in preclinical models of tissue repair; human clinical evidence is limited.
Teduglutide (also known as Gattex) is a peptide catalogued under Gastrointestinal (GLP-2 analog). It is described as: GLP-2 receptor. Documented context: Short bowel syndrome. Neutral reference entry; EU status: EU-approved prescription medicine.
Teicoplanin (also known as Targocid) is a peptide catalogued under Cyclic & Antimicrobial (Glycopeptide antibiotic). It is described as: D-Ala-D-Ala. Documented context: Gram-positive infections. Neutral reference entry; EU status: EU-approved prescription medicine.
Telavancin (also known as Vibativ) is a peptide catalogued under Cyclic & Antimicrobial (Lipoglycopeptide). It is described as: Cell wall + membrane. Documented context: HABP/VABP; ABSSSI. Neutral reference entry; EU status: EU-approved prescription medicine.
Temsirolimus is a peptide catalogued under Cyclic & Antimicrobial. Neutral reference entry; EU status: EU-approved prescription medicine.
Tenecteplase (also known as TNKase) is a peptide catalogued under Enzymes (Modified tPA). Neutral reference entry; EU status: EU-approved prescription medicine.
Teriparatide (also known as Forteo) is a peptide catalogued under Hormones & Metabolic (PTH analog). It is described as: PTH1R. Documented context: Osteoporosis. Neutral reference entry; EU status: EU-approved prescription medicine.
Terlipressin (also known as Glypressin) is a peptide catalogued under Sexual Health (Vasopressin analog). It is described as: V1 receptor agonist. Documented context: Hepatorenal syndrome; esophageal varices. Neutral reference entry; EU status: EU-approved prescription medicine.
A stabilized growth-hormone-releasing hormone analog approved (as Egrifta) to reduce excess abdominal fat in HIV-associated lipodystrophy.
Testagen is a peptide catalogued under Bioregulators (Khavinson (testis)). Neutral reference entry; EU status: not approved for human use (research use only).
Tetrapeptide-12 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Tetrapeptide-21 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Tetrapeptide-30 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
A thymus-derived polypeptide preparation studied in Russia for immunomodulatory effects in older adults.
Thymogen (also known as Glutamyl-tryptophan) is a peptide catalogued under Bioregulators (Khavinson dipeptide). Neutral reference entry; EU status: not approved for human use (research use only).
Thymosin alpha-1 is a peptide catalogued under Immune. Neutral reference entry; EU status: EU-approved prescription medicine.
Thymosin beta-4 is a peptide catalogued under Longevity & Anti-Aging. Neutral reference entry; EU status: not approved for human use (research use only).
Thyrotropin alfa (also known as Thyrogen) is a peptide catalogued under Hormones & Metabolic (Recombinant TSH). Neutral reference entry; EU status: EU-approved prescription medicine.
Thyrotropin-releasing hormone (also known as TRH) is a peptide catalogued under Hormones & Metabolic (Hypothalamic tripeptide). It is described as: TRH receptor. Documented context: Diagnostic. Neutral reference entry; EU status: EU-approved prescription medicine.
A dual GIP/GLP-1 receptor agonist approved for type 2 diabetes (Mounjaro) and weight management (Zepbound), with large phase-3 trial programs.
Tripeptide-1 (also known as GHK) is a peptide catalogued under Skin. It is described as: Copper carrier; regeneration. Neutral reference entry; EU status: EU cosmetic ingredient.
Tripeptide-10 citrulline (also known as Decorinyl) is a peptide catalogued under Skin (Decorin mimetic). Neutral reference entry; EU status: EU cosmetic ingredient.
Tripeptide-29 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Tripeptide-3 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Tripeptide-32 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Tripeptide-4 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Tripeptide-41 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Tripeptide-5 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Tripeptide-6 is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Tripeptide-9 citrulline is a peptide catalogued under Skin. Neutral reference entry; EU status: EU cosmetic ingredient.
Triptorelin (also known as Trelstar) is a peptide catalogued under Sexual Health (GnRH agonist). It is described as: GnRH receptor agonist. Documented context: Prostate cancer. Neutral reference entry; EU status: EU-approved prescription medicine.
Trofinetide (also known as Daybue) is a peptide catalogued under Therapeutic Peptides (Glypromate analog (tripeptide)). It is described as: IGF-1 pathway modulator. Documented context: Rett syndrome. Neutral reference entry; EU status: EU-approved prescription medicine.
Tyrothricin is a peptide catalogued under Cyclic & Antimicrobial (Peptide mixture (gramicidin+tyrocidine)). Neutral reference entry; EU status: available as an EU supplement.
Urofollitropin (also known as Bravelle) is a peptide catalogued under Sexual Health (Urinary FSH). Neutral reference entry; EU status: EU-approved prescription medicine.
Urokinase (also known as uPA) is a peptide catalogued under Enzymes. Neutral reference entry; EU status: EU-approved prescription medicine.
Vancomycin (also known as Vancocin) is a peptide catalogued under Cyclic & Antimicrobial (Glycopeptide antibiotic). It is described as: D-Ala-D-Ala peptidoglycan. Documented context: MRSA; C. difficile. Neutral reference entry; EU status: EU-approved prescription medicine.
Vasopressin (also known as Argipressin) is a peptide catalogued under Sexual Health (Neurohypophyseal hormone). It is described as: V1a/V1b/V2 receptor. Documented context: Diabetes insipidus; vasodilatory shock. Neutral reference entry; EU status: EU-approved prescription medicine.
Velaglucerase alfa (also known as VPRIV) is a peptide catalogued under Enzymes (Gaucher). Neutral reference entry; EU status: EU-approved prescription medicine.
Ventfort is a peptide catalogued under Bioregulators (Khavinson (vascular)). Neutral reference entry; EU status: not approved for human use (research use only).
Vestronidase alfa (also known as Mepsevii) is a peptide catalogued under Enzymes (MPS VII). Neutral reference entry; EU status: EU-approved prescription medicine.
Vesugen (also known as Lys-Glu-Asp) is a peptide catalogued under Bioregulators (Khavinson tripeptide (vascular)). Neutral reference entry; EU status: not approved for human use (research use only).
Vialox (also known as Pentapeptide-3) is a peptide catalogued under Skin (Muscle relaxing). It is described as: nAChR antagonist. Neutral reference entry; EU status: EU cosmetic ingredient.
Vilon (also known as Lys-Glu) is a peptide catalogued under Bioregulators (Khavinson dipeptide). Neutral reference entry; EU status: not approved for human use (research use only).
Voclosporin (also known as Lupkynis) is a peptide catalogued under Cyclic & Antimicrobial (Cyclosporin analog). It is described as: Calcineurin. Documented context: Lupus nephritis. Neutral reference entry; EU status: EU-approved prescription medicine.
A synthetic cone-snail venom peptide (N-type calcium-channel blocker), FDA-approved for severe chronic pain via intrathecal infusion; carries a boxed warning.
Zilucoplan (also known as Zilbrysq) is a peptide catalogued under Therapeutic Peptides (Complement C5 inhibitor). It is described as: C5 complement. Documented context: Generalized myasthenia gravis. Neutral reference entry; EU status: EU-approved prescription medicine.